Dotbee.ai

Analysis Profound Medical Corp (PROF)

5/27/2024

Analysis Profound Medical Corp (PROF)

Analysis of Profound Medical Corp (PROF)

Profound Medical Corp (PROF) has been showing some interesting price movements and technical indicators in the past few days:

1. Price Movement:
- The stock price has been fluctuating between $7.31 and $8.54 over the past 10 days.
- There was a significant drop in price on May 14th, but the price has been recovering since then.

2. Relative Strength Index (RSI):
- The RSI values have been fluctuating between 39.61 and 60.12, indicating some volatility in the stock.
- The RSI is currently around 46.86, suggesting a neutral stance.

3. Moving Average Convergence Divergence (MACD):
- The MACD line has been crossing above and below the signal line, indicating some indecision in the market.
- The MACD histogram has been positive for the past few days, suggesting a bullish momentum.

4. Moving Averages:
- The stock price is currently below the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) values, indicating a bearish trend.

Overall, Profound Medical Corp's stock has been experiencing some volatility, with mixed signals from technical indicators. Traders and investors may want to closely monitor the price movements and wait for more clarity in the trend before making any trading decisions.

Earnings

The company's results for the most recent quarter ending on April 30, 2025, have not been provided yet. The previous results were reported on February 27, 2025, through the Transfer Agent. Before that, on January 31, 2025, the results were released after hours. The results for the quarter ending on October 31, 2024, were not provided on time. However, on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.33.

Main Statystic 🧠

The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits for a specific company.

In terms of financials, the company has strong cash flow with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet shows a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31% and the company's fiscal year ends on September 30, 2023. The income statement reveals an EBITDA of $131.39 billion, revenue of $381.62 billion, and a diluted EPS of 6.44.

Moving on to stock statistics, the company has a short ratio of 1.66, with 94.31 million shares shorted out of 15.31 billion float shares. The average 10-day volume is 52.90 million shares, while the average 90-day volume is 62.82 million shares. The stock has a market capitalization of $2.91 trillion.

Valuation metrics show a PEG ratio of 26.21, forward P/E of 26.21, and trailing P/E of 29.43. The enterprise value is $2.95 trillion, with a price-to-book ratio of 39.18 and price-to-sales ratio of 7.62. The stock has an enterprise-to-EBITDA ratio of 22.75 and an enterprise-to-revenue ratio of 7.73.

The stock price summary includes a beta of 1.26, with a 50-day moving average of $173.69 and a 200-day moving average of $180.79. The stock's 52-week low is $164.08, high is $199.62, and the change over the past 52 weeks is 8.25%.

Lastly, in terms of dividends and splits, the company has a payout ratio of 14.93% and a forward annual dividend rate of $1. The stock's ex-dividend date is May 10, 2024, with a dividend date of May 16, 2024. The last split date was on August 31, 2020, with a 4-for-1 split. The 5-year average dividend yield is 0.73% and the trailing annual dividend yield is 0.51%.

Income statement 💸

These are the revenues. Here are the conclusions:

1. The company's sales have been increasing over the years, from $274.52 billion in 2020 to $383.29 billion in 2023.
2. The gross profit margin has been relatively stable, with gross profit ranging from $104.96 billion to $169.15 billion.
3. Operating income has also shown an increasing trend, from $66.29 billion in 2020 to $114.30 billion in 2023.
4. Net income has been increasing steadily, from $57.41 billion in 2020 to $96.99 billion in 2023.
5. Earnings per share (EPS) have shown a slight fluctuation but have generally increased over the years.
6. The company has been able to maintain a healthy EBITDA margin, with EBITDA ranging from $81.02 billion to $129.18 billion.
7. Despite an increase in income tax expenses, the company has managed to grow its net income consistently.
8. The company has been able to control its operating expenses effectively, allowing for growth in operating income.
9. Overall, the financial performance of the company in terms of revenues has been positive, showing growth in sales, income, and profitability over the years.

Balance Sheet

These are balance sheets. Here are the conclusions:

1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2018 at $107,147,000,000.
6. The company seems to be investing more in non-current assets over the years, which might indicate long-term growth strategies.

Cash Flow 💶

This is the cash flow statement. Here are some conclusions we can draw from the data:

1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational performance and strategic investments.

Earnings estimate

The analysts' estimates for future quarterly and annual earnings per share are as follows:

1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26

2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25

3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39

4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39

Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and the next two years. The average estimates are showing growth compared to the year-ago EPS figures, indicating optimism among analysts regarding the company's performance.

Revenue estimate

Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:

1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.

2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.

3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.

4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.

These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with a slightly higher growth rate expected in the next fiscal year.

Growth estimates

Based on the consensus estimates provided, we can draw the following conclusions about the growth rate of the company for different periods:

1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 11%.

These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the next 5 years compared to the past 5 years. The company is projected to experience steady growth in the upcoming quarters and years, indicating a positive outlook according to analyst consensus.

Price target

The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD

Based on these forecasts, we can see that the analysts have a wide range of opinions on the future price of the security, with the low end at $164, the high end at $250, and the average at $202.26. The current price is below both the average and median forecast, indicating that there is potential upside according to the analysts' predictions.

MACD of PROF

This is not investment advice. Remember to verify the information provided here.

Get access to the full analysis

  • Over 35 000 indexes
  • CFD, Forex, Crypto and Stocks Exchange
  • Over 150 Indicators
  • Pattern and candle analysis
  • Support and resistance levels
  • Fundamental, technical and sentimental analysis
  • Power from AI
Web versionApp StoreGoogle Play

Contacts

Telephone number

+48 32 700 81 66

Email address

[email protected]

Company information

Honey Payment Group S.A. at Al. Aleje Jerozolimskie 65 / 79, 00-697 Warsaw, Poland, Register number KRS 0000335507, NIP 5252859204, REGON 388760204. Honey Payment Group is listed on the Warsaw Stock Exchange (WSE) under the ticker symbol HPG. Link